The global prefilled syringes market was worth USD 5.31 billion in 2020. It is expected to grow at the CAGR of 8.5% during 2021-2027 (forecast period), earning revenue of around USD 9.40 billion by the end of 2027. This is due to rise in demand for efficient and easy-to-use drug delivery devices and rise in efforts of healthcare professionals to reduce human errors in drug delivery. Moreover, increase in adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations) are positively impacting the growth of global prefilled syringes market.

A “prefilled syringe” is generally a syringe which is filled with a fixed quantity of a therapeutic drug. These are novel devices which are used for delivering drugs with improved accuracy, affordability, efficacy, convenience, sterility, safety, and accessibility. These characteristics provide it an advantage over traditional systems of drug delivery, which requires glass or metal vials to store pharmaceutical drugs.





Source: BlueWeave Consulting

Global Prefilled Syringes Market Overview

The prefilled syringes make injections easy to use, accurate, and safe for both, patients and doctors. As the pharmaceutical industry seeks new and more suitable drug delivery techniques, pre-filled syringes have emerged as one of the fastest-growing options for unit dose medication. The key drivers responsible for the growth of the global prefilled syringes market are the rising concerns associated with needle stick injuries, as well as the advantages of prefilled syringes over conventional vials and syringe packaging systems. Furthermore, increased demand for point-of-care administration, as well as the growing prevalence of chronic and lifestyle-related disorders, are propelling the prefilled syringes market forward.

Global Prefilled Syringes Market Forecast and Trends

Growth Drivers

Rising Adoption of Customized Prefilled Syringes

The formulations for injectables are growing more complex. They require strict quality control in order to match customer requirements. Thus, manufacturers As a result, manufacturers have begun to focus on the development and production of prefilled syringes that may be used by individuals on their own. Therefore, the focus of syringe manufacturers across the globe is shifting toward self-managing dose syringes, rather than syringes used by hospitals or any other healthcare providers. These changes are proliferating the growth of prefilled syringes market.

Restraints

Complex Manufacturing Process and Product Recalls

The risk of hazardous exposure is considerably reduced when prefilled syringes are used to load drugs from vials. However, the use of bare prefilled syringes without safety devices, on the other hand, can also result in needle stick injuries. Moreover, products recalls due to the presence of certain contamination or leakages in the syringes are responsible for hampering the market. For instance, in April 16 2020, BD Pharma announced a voluntary, consumer-level medical device recall of numerous batches of PosiFlush SF (sterile field) saline flush syringes due to defects in the packaging that damaged package integrity and potentially compromised a sterile field.

Impact of COVID-19 on Global Prefilled Syringes Market

The COVID-19 outbreak has positively impacted the global prefilled syringes market. Because of the reduced danger of needle-stick injuries, demand for prefilled syringes has surged over glass vials. Additionally, in order to increase production of the COVID-19 vaccine, manufacturers are increasing their capacity for prefilled syringes. For instance, a deal of USD 138 million was signed by the U.S. government with syringe manufacturers in order to produce 100 million prefilled syringes for the coronavirus vaccine by the end of 2020, and more than 500 million by 2021.

Global Prefilled Syringes Market- By Closing System


Based on the closing system, the global prefilled syringes market is bifurcated into staked needle system, luer cone system, and luer lock form system. Among these, the staked needle segment held the largest market share in 2020 due to its growing usage. However, due to an increase in needle stick injuries, its market is expected to shrink in the coming years. In addition, technological advancements in luer lock form systems are proving to be a more secure technique of reducing needle-stick injuries.









Source: BlueWeave Consulting



Global Prefilled Syringes Market- By Therapeutic Area

Based on the therapeutic area, the global prefilled syringes market is grouped into anaphylaxis, rheumatoid arthritis, diabetes, autoimmune disorders, infectious diseases, neurological disorders, blood disorders, psychiatric disorders, respiratory disorders, cardiovascular disorders, metabolic disorders, ophthalmic diseases and others. Among these segments, the diabetes segment held the largest market share due to the growing prevalence of the disease and the need for effective and safer insulin delivery devices, which in turn is propelling the growth of the global prefilled syringes market. Anaphylaxis, on the other hand, is the fastest-growing segment due to technological advancements and public awareness campaigns.

Global Prefilled Syringes Market- By Distribution Channel

Based on the distribution channel, the global prefilled syringes market is segmented into hospital, mail order pharmacies, and ambulatory surgery centers. Among these, the hospital segment accounted for the largest share in the market in 2020 due to the various advantage offered by prefilled syringes such as availability of affordable syringes and the rise in usage of prefilled syringes in regular OPDs. These products minimizes the wastage of APIs during the dose preparation process. Therefore, costly drugs are mostly administered via these devices, which are filled precisely using automated machines.

Global Prefilled Syringes Market- By End-User

Based on the end-user, the global prefilled syringes market is segmented into pharmaceutical & biotechnology companies, contract research & manufacturing organizations and others. Among these, pharmaceutical & biotechnology companies segment held the major market share in 2020 due to the rapid-expansion of pharmaceutical companies worldwide. They are majorly into biosimilars, biologics and vaccines. These companies have increased their demand for new drug delivery system like syringes that are prescribed with a unit of medication for better patient compliance. This rise in demand for innovative injectable drug delivery systems is further likely to propel the growth of pharmaceutical & biotechnology companies segment in the forecast period.

Global Prefilled Syringes Market- By Region

Based on region, the global prefilled syringes market is segmented into five regions, North America, Europe, the Asia-Pacific, Latin America and the Middle East & Africa. Among these, Europe held the largest market share in 2020 due to the increase in demand for prefilled syringes in the region. This is owing to an increase in the number of patients adopting biologics as treatment alternatives for chronic disease, as well as widespread acceptance of technologically advanced ways for self-injecting medications. Furthermore, The European Board of Anesthesiology has also recommended the use of prefilled syringes for anesthesia.The Asia-Pacific is also catching up as the fastest-growing region Due to the increasing prevalence of chronic diseases and a rapidly growing patient population.



Source: BlueWeave Consulting

Competitive Landscape

The global prefilled syringes market is competitive in nature due to the presence of many major players in the market. The key players in the market are Gerresheimer AG, Schott AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Vetter Pharma International Gmbh, Weigao Group, Ompi (A Stevanato Group Company), Catalent, Inc., Nipro Corporation, Baxter International Inc., Elcam Medical, Ypsomed, Oval Medical Technologies Ltd., Shl Medical Ag., Terumo Corporation, Medtronic Plc, Gerresheimer, Abbott, Nipro Medical Corporation, and other prominent players.

Recent Developments

· In May 2021, AMGEVITA, an abdalimumab biosimilar was launched by Amgen Canada for the treatment of 11 chronic inflammatory conditions. AMGEVITA is available as a prefilled syringe and a prefilled pen. They are also available in different range of pack sizes to support dosing as per the approval dosage recommendations in each indication. It is also provided in a citrate-free formulation.

· In October 2020, Stevanato Group and Gerresheimer AGhas signed an agreement in which Stevanato Group has agreed to provide its SG integrated tip cap (ITC) closure system to Gerresheimer AG for Gx RTF syringes, which would be provided to various pharmaceutical companies. This would enhance the safety of the products such as prefilled syringes, and therefore, expand their customer base.



Scope of Report

Attribute

Details

Years considered

Historical data- 2017-2020

Base Year- 2020

Forecast- 2021-2027

Facts covered

Revenue in USD Billion

Market coverage

North America (U.S. and Canada), Europe (Germany, U.K., Italy, France, Spain), the Asia-Pacific (China, India, Japan, Singapore, South Korea), Latin America (Brazil, Argentina, Columbia, Mexico) and the Middle-East & Africa (Saudi-Arabia, Iran, UAE, Turkey, South Africa)

Product/ Service segmentation

By Type, By Material, By Design, By Closing System, By Therapeutics Area, By Distribution Channel, By End-User and By Region

Key Players

Gerresheimer AG, Schott AG, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Vetter Pharma International Gmbh, Weigao Group, Ompi (A Stevanato Group Company), Catalent, Inc., Nipro Corporation, Baxter International Inc., Elcam Medical, Ypsomed, Oval Medical Technologies Ltd., Shl Medical Ag, Terumo Corporation, Medtronic Plc, Gerresheimer, Abbott, Nipro Medical Corporation, and other prominent players.



By Type

Ø Conventional

Ø Safety

By Material

Ø Glass

Ø Plastic

By Design

Ø Single-Chamber

Ø Dual-Chamber

Ø Customized

By Closing System

Ø Stacked Needle System

Ø Luer Cone System

Ø Luer Lock Form System

By Therapeutics Area

Ø Autoimmune Disorders

Ø Infectious Diseases

Ø Neurological Disorders

Ø Blood Disorders

Ø Psychiatric Disorders

Ø Respiratory Disorders

Ø Cardiovascular Disorders

Ø Metabolic Disorders

Ø Ophthalmic Diseases

Ø Anaphylaxis

Ø Rheumatoid Arthritis

Ø Diabetes

Ø Other Applications

By Distribution Channel

Ø Hospitals

Ø Mail Order Pharmacies

Ø Ambulatory Surgery Centres

By End-User

Ø Pharmaceutical & Biotechnology Companies

Ø Contract Research & Manufacturing Organizations

Ø Others

By Region

Ø North America

Ø Europe

Ø the Asia-Pacific

Ø Latin America

Ø the Middle East and Africa